Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 04, 2021, titled "Dr. Reddy s Laboratories announces entry into definitive agreement with BioDelivery Sciences International, Inc., to sell its U.S. and Canada territory rights for ELYXYB (celecoxib oral solution) 25 mg/mL".
Press Release Aug 04 2021
Filed with NSE · · 4 pages · English
Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings Call · Replay · Oct 23Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings CallRelease
Dr. Reddy's Laboratories Ltd. on 6ix
Earlier from Dr. Reddy's Laboratories
- Press Release Aug 03 2021
- Press Release Jul 27 2021
- Press Release Jul 07 2021
- Press Release Jun 30 2021
- Press Release Jun 29 2021
Later from Dr. Reddy's Laboratories
- Press Release Aug 31 2021
- Press Release Sep 02 2021
- Press Release Sep 04 2021
- Press Release Sep 07 2021
- Press Release Oct 07 2021
Follow Dr. Reddy's Laboratories into a list and get an email when it puts out news.
Follow Dr. Reddy's Laboratories